{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:21:36Z","timestamp":1778646096010,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jinf.2021.07.036","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T12:11:15Z","timestamp":1627560675000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries"],"prefix":"10.1016","volume":"83","author":[{"given":"Bih H.","family":"Chendi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hallgeir","family":"Tveiten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice I.","family":"Snyders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Tonby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Synne","family":"Jenum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malene","family":"Hove-Skovsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novel N.","family":"Chegou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M","family":"Dyrhol-Riise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.07.036_bib0001","unstructured":"World Health Organisation. Global tuberculosis report, 2020. Available at https:\/\/www.who.int\/publications\/i\/item\/9789240013131."},{"issue":"12","key":"10.1016\/j.jinf.2021.07.036_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900174","article-title":"Tuberculosis in the European Union\/European economic area: much progress, still many challenges","volume":"24","author":"Guthmann","year":"2019","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0004","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.jinf.2021.07.036_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thx.2007.085340","article-title":"Highly discordant T cell responses in individuals with recent exposure to household tuberculosis","volume":"64","author":"Hesseling","year":"2009","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1513\/pats.200511-119JH","article-title":"Advances in the diagnosis and treatment of tuberculosis","volume":"3","author":"Nahid","year":"2006","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/eri.11.23","article-title":"Tuberculosis assays: past, present and future","volume":"9","author":"Chegou","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2021.07.036_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/814943","article-title":"Pathogenesis, immunology, and diagnosis of latent mycobacterium tuberculosis infection","author":"Ahmad","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jinf.2021.07.036_bib0009","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1183\/13993003.01910-2015","article-title":"Diagnostics for latent TB infection: incremental, not transformative progress","volume":"47","author":"Pai","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.036_bib0010","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0011","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018515","article-title":"Clinical immunology and multiplex biomarkers of human tuberculosis","volume":"5","author":"Walzl","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.jinf.2021.07.036_bib0012","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.3389\/fmicb.2019.02789","article-title":"Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects","volume":"10","author":"Yong","year":"2019","journal-title":"Front Microbiol."},{"issue":"3","key":"10.1016\/j.jinf.2021.07.036_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jinf.2016.04.036","article-title":"Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease","volume":"73","author":"Awoniyi","year":"2016","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.036_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0038501","article-title":"Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area","volume":"7","author":"Chegou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2021.07.036_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.036_bib0016","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-018-1572-x","article-title":"Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB","volume":"16","author":"Wang","year":"2018","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2012.11.005","article-title":"Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection","volume":"66","author":"Mihret","year":"2013","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2021.07.036_bib0021","first-page":"2020","article-title":"Gaps in study design for immune parameter research for latent tuberculosis infection: a systematic review","author":"Herrera","year":"2020","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.036_bib0022","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jinf.2020.09.032","article-title":"Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: a systematic review","volume":"81","author":"Sudbury","year":"2020","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.jinf.2021.07.036_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039501","article-title":"Evaluation of cytokines as a biomarker to distinguish active tuberculosis from latent tuberculosis infection: a diagnostic meta-analysis","volume":"10","author":"Qiu","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-020-01280-x","article-title":"The meta-analysis for ideal cytokines to distinguish the latent and active TB infection","volume":"20","author":"Wei","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jinf.2021.07.036_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tube.2011.01.001","article-title":"A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis","volume":"91","author":"Ruhwald","year":"2011","journal-title":"Tuberculosis"},{"issue":"10","key":"10.1016\/j.jinf.2021.07.036_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039501","article-title":"Evaluation of cytokines as a biomarker to distinguish active tuberculosis from latent tuberculosis infection: a diagnostic meta-analysis","volume":"10","author":"Qiu","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.036_bib0027","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.00117-12","article-title":"Multicytokine detection improves latent tuberculosis diagnosis in health care workers","volume":"50","author":"Rubbo","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.036_bib0028","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","article-title":"A systematic review of biomarkers to detect active tuberculosis","volume":"4","author":"MacLean","year":"2019","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.036_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: from diagnosis to protection","volume":"8","author":"Goletti","year":"2016","journal-title":"Infect Dis Rep"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.036_bib0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/thoraxjnl-2015-207999","article-title":"Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB","volume":"71","author":"Chegou","year":"2016","journal-title":"Thorax"},{"issue":"36","key":"10.1016\/j.jinf.2021.07.036_bib0031","doi-asserted-by":"crossref","first-page":"57581","DOI":"10.18632\/oncotarget.11420","article-title":"Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response","volume":"7","author":"Jacobs","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinf.2021.07.036_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tube.2018.05.004","article-title":"IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring","volume":"111","author":"Zhao","year":"2018","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20855-7","article-title":"Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis","volume":"8","author":"Chegou","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood.V97.1.39","article-title":"The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium","volume":"97","author":"Haque","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.036_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.036_bib0036","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jinf.2021.07.036_bib0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4614-6111-1_9","article-title":"Foxp3+ regulatory T cells in Tuberculosis","volume":"783","author":"Larson","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"10.1016\/j.jinf.2021.07.036_bib0038","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"Guyot-Revol","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.036_bib0039","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tube.2007.07.004","article-title":"Increased frequency of CD4+CD25high Treg cells inhibit BCG-specific induction of IFN-\u03b3 by CD4+ T cells from TB patients","volume":"87","author":"Li","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2021.07.036_bib0040","doi-asserted-by":"crossref","unstructured":"Angerami M.T., Suarez G.V., Vecchione M.B., et\u00a0al. Expansion of CD25-negative forkhead Box P3-positive T cells during HIV and mycobacterium tuberculosis infection. Front Immunol. (2017);8(MAY):1. doi: 10.3389\/fimmu.2017.00528","DOI":"10.3389\/fimmu.2017.00528"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0041","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0035-9203(01)90212-3","article-title":"Lack of induction of interleukin-2-receptor-a in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis","volume":"95","author":"Lawn","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0042","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0962-8479(96)90105-7","article-title":"Correlation of serum interleukin-2 receptor-\u03b1 levels with clinical manifestations in pulmonary tuberculosis","volume":"77","author":"Rajalingam","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.jinf.2021.07.036_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.608846","article-title":"A plasma 5-marker host biosignature identifies tuberculosis in high and low endemic countries","volume":"12","author":"Chendi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2021.07.036_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.607827","article-title":"Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease","volume":"12","author":"Mutavhatsindi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2021.07.036_bib0045","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202007-2686OC","article-title":"Antigen-specific T cell activation distinguishes between recent and remote tuberculosis infection","author":"Mpande","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2021.07.036_bib0046","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1164\/rccm.201601-0116LE","article-title":"Activation profile of Mycobacterium tuberculosis Specific CD4+ T cells reflects disease activity irrespective of HIV status","volume":"193","author":"Wilkinson","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.036_bib0047","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","article-title":"IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy","volume":"70","author":"Wergeland","year":"2015","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0048","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1038\/s41598-019-40458-0","article-title":"IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting","volume":"9","author":"Hoel","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2021.07.036_bib0049","series-title":"High-Priority Target Product Profiles for New Tuberculosis Diagnostics","year":"2017"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.036_bib0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.26948","article-title":"The architecture of diagnostic research: from bench to bedside-research guidelines using liver stiffness as an example","volume":"60","author":"Colli","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jinf.2021.07.036_bib0051","volume":"9","author":"Coussens","year":"2013"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.036_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163848","article-title":"Cytokine patterns in tuberculosis infection; IL-1ra, IL-2 and IP-10 differentiate borderline QuantiFERON-TB samples from uninfected controls","volume":"11","author":"Wergeland","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:26Z","timestamp":1759008806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321003790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0163445321003790"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.036","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}